Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)

H. Lee Moffitt Cancer Center and Research Institute · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
lungnsclc
non-small-cell lung carcinoma, erlotinib, dasatinib, epidermal growth factor receptor (egfr), tyrosine kinase, nsclc, pharmacokinetics (pk), lung, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 840475
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.